9 research outputs found
The 10,000-year biocultural history of fallow deer and its implications for conservation policy
Over the last 10,000 y, humans have manipulated fallow deer populations with varying outcomes. Persian fallow deer (Dama mesopotamica) are now endangered. European fallow deer (Dama dama) are globally widespread and are simultaneously considered wild, domestic, endangered, invasive and are even the national animal of Barbuda and Antigua. Despite their close association with people, there is no consensus regarding their natural ranges or the timing and circumstances of their human-mediated translocations and extirpations. Our mitochondrial analyses of modern and archaeological specimens revealed two distinct clades of European fallow deer present in Anatolia and the Balkans. Zooarchaeological evidence suggests these regions were their sole glacial refugia. By combining biomolecular analyses with archaeological and textual evidence, we chart the declining distribution of Persian fallow deer and demonstrate that humans repeatedly translocated European fallow deer, sourced from the most geographically distant populations. Deer taken to Neolithic Chios and Rhodes derived not from nearby Anatolia, but from the Balkans. Though fallow deer were translocated throughout the Mediterranean as part of their association with the Greco-Roman goddesses Artemis and Diana, deer taken to Roman Mallorca were not locally available Dama dama, but Dama mesopotamica. Romans also initially introduced fallow deer to Northern Europe but the species became extinct and was reintroduced in the medieval period, this time from Anatolia. European colonial powers then transported deer populations across the globe. The biocultural histories of fallow deer challenge preconceptions about the divisions between wild and domestic species and provide information that should underpin modern management strategies
Tuberculosis incidence in foreign-born people residing in European countries in 2020.
BackgroundEuropean-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.AimWe aimed to identify groups of foreign-born individuals residing in European countries that benefit most from targeted TB prevention screening.MethodsThe Tuberculosis Network European Trials group collected, by cross-sectional survey, numbers of foreign-born TB patients residing in European Union (EU) countries, Iceland, Norway, Switzerland and the United Kingdom (UK) in 2020 from the 10 highest ranked countries of origin in terms of TB cases in each country of residence. Tuberculosis incidence rates (IRs) in countries of residence were compared with countries of origin.ResultsData on 9,116 foreign-born TB patients in 30 countries of residence were collected. Main countries of origin were Eritrea, India, Pakistan, Morocco, Romania and Somalia. Tuberculosis IRs were highest in patients of Eritrean and Somali origin in Greece and Malta (both > 1,000/100,000) and lowest among Ukrainian patients in Poland (3.6/100,000). They were mainly lower in countries of residence than countries of origin. However, IRs among Eritreans and Somalis in Greece and Malta were five times higher than in Eritrea and Somalia. Similarly, IRs among Eritreans in Germany, the Netherlands and the UK were four times higher than in Eritrea.ConclusionsCountry of origin TB IR is an insufficient indicator when targeting foreign-born populations for active case finding or TB prevention policies in the countries covered here. Elimination strategies should be informed by regularly collected country-specific data to address rapidly changing epidemiology and associated risks
Recommended from our members
The 10,000-year biocultural history of fallow deer and its implications for conservation policy
Over the last 10,000 y, humans have manipulated fallow deer populations with varying outcomes. Persian fallow deer ( Dama mesopotamica ) are now endangered. European fallow deer ( Dama dama ) are globally widespread and are simultaneously considered wild, domestic, endangered, invasive and are even the national animal of Barbuda and Antigua. Despite their close association with people, there is no consensus regarding their natural ranges or the timing and circumstances of their human-mediated translocations and extirpations. Our mitochondrial analyses of modern and archaeological specimens revealed two distinct clades of European fallow deer present in Anatolia and the Balkans. Zooarchaeological evidence suggests these regions were their sole glacial refugia. By combining biomolecular analyses with archaeological and textual evidence, we chart the declining distribution of Persian fallow deer and demonstrate that humans repeatedly translocated European fallow deer, sourced from the most geographically distant populations. Deer taken to Neolithic Chios and Rhodes derived not from nearby Anatolia, but from the Balkans. Though fallow deer were translocated throughout the Mediterranean as part of their association with the Greco-Roman goddesses Artemis and Diana, deer taken to Roman Mallorca were not locally available Dama dama , but Dama mesopotamica . Romans also initially introduced fallow deer to Northern Europe but the species became extinct and was reintroduced in the medieval period, this time from Anatolia. European colonial powers then transported deer populations across the globe. The biocultural histories of fallow deer challenge preconceptions about the divisions between wild and domestic species and provide information that should underpin modern management strategies
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
Rationale: Multidrug-resistant tuberculosis (MDR-TB) is a major
burden to public health in Europe. Reported treatment success rates
are around 50% or less, and cure rates are even lower.
Objectives: To document the management and treatment outcome
in patients with MDR-TB in Europe.
Methods: We performed a prospective cohort study, analyzing
management and treatment outcomes stratified by incidence of
patients with MDR-TB in Europe. Treatment outcomes were
compared by World Health Organization and alternative simplified
definitions by the Tuberculosis Network European Trialsgroup
(TBNET).
Measurements and Main Results: A total of 380 patients with
MDR-TB were recruited and followed up between 2010 and 2014
in 16 European countries. Patients in high-incidence countries
compared with low-incidence countries were treated more
frequently with standardized regimen (83.2% vs. 9.9%), had delayed
treatment initiation (median, 111 vs. 28 d), developed more
additional drug resistance (23% vs. 5.8%), and had increased
mortality (9.4% vs. 1.9%). Only 20.1% of patients using
pyrazinamide had proven susceptibility to the drug. Applying
World Health Organization outcome definitions, frequency of cure
(38.7% vs. 9.7%) was higher in high-incidence countries. Simplified
outcome definitions that include 1 year of follow-up after the
end of treatment showed similar frequency of relapse-free cure in
low- (58.3%), intermediate- (55.8%), and high-incidence (57.1%)
countries, but highest frequency of failure in high-incidence
countries (24.1% vs. 14.6%).
Conclusions: Conventional standard MDR-TB treatment regimens
resulted in a higher frequency of failure compared with individualized
treatments. Overall, cure from MDR-TB is substantially more
frequent than previously anticipated, and poorly reflected by World
Health Organization outcome definitions.German Center for Infection Researc